Facebook
Twitter
LinkedIn
ForwardOMA 2023 Spring Summit: The Role of Continuous Glucose Monitoring (CGM) in Obesity Management (On Demand)
This presentation will provide an overview of the evidence basis for using continuous glucose monitoring (CGM) in patients with obesity. Additional discussion includes patient types and practice settings where CGM provides the highest utility in the management of obesity. We will also identify the gaps in the current body of evidence, which create the need and determine the direction of future research. Lastly, the presentation will discuss future sensors in development that promise to continuously monitor other chemicals, such as lactate and ketones.
CME/CE Expiration Date: 4/23/26
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
David Ahn, MD
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.